This online educational activity is targeted to pharmacists providing care to patients with asthma. The activity consists of two patient case scenarios: the first case involving a 54-year-old female patient recently diagnosed with asthma. The second case involves a 6-year-old male patient with asthma and eczema.
Both cases include 5 multiple-choice questions that address patient-related factors a pharmacist should consider when selecting among available inhaler devices for the treatment of asthma. Each question is also followed by a rationale.
At the completion of this application-based activity, pharmacists will be able to:
- Given patient cases, discuss evidence-based care plans for patients with asthma.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0202-0000-17-227-H01-P.
To obtain 1.0 contact hour of CPE credit (0.10 CEU) for "Patient Case Studies: Asthma" complete the activity and evaluation questions, then CLAIM credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: August 10, 2017
Expiration date: August 10, 2020 - NO CREDIT GRANTED AFTER THIS DATE
"Patient Case Studies: Asthma" is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.
This educational activity is supported by an educational grant from GlaxoSmithKline.
Dennis Williams, PharmD, BCPS, AE-C, declares that his spouse/partner is an employee and a stock/shareholder of GlaxoSmithKline.
Lori Wilken, PharmD and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures .
Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
Computer and Internet access is required to complete this activity. Please visit our website to view the System Requirements to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-17-227-H01-P||0.1 CEUs||August 10, 2017 - August 10, 2020|